Phencyclidine (PCP)

Safety Summary

Regulatory Status

Sources

These citations are the ones recorded for the human adult context.

• US DEA: Phencyclidine (PCP) — Schedule II Classification, NMDA Receptor Antagonism, Schizophrenia Model Drug, Clinical Toxidrome (Nystagmus, Dissociation, Analgesia, Agitation), and Veterinary Sernylan History (2022) REGULATORY · 2022
• Goldfrank's Toxicologic Emergencies: Phencyclidine and Ketamine — NMDA Antagonist Toxidrome, Nystagmus Triad, Hyperthermia Risk with Physical Restraint, Benzodiazepine Management, and Differential Diagnosis from Excited Delirium (11th Ed., 2019) ACADEMIC · 2019
• OEHHA Proposition 65 List of Carcinogens or Reproductive Toxicants (CSV, list date 31-Jul-26) REGULATORY
• where to look DrugBank, as recorded by PubChem (Experimental Properties, CID 6468; where-to-look, not a source of this value) DATABASE · 2026
• EPA CompTox CTX API: predicted properties for DTXSID6023446 (Phencyclidine (PCP)) REFERENCE

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.